Literature DB >> 26675505

Development of a Fluorinated Class-I HDAC Radiotracer Reveals Key Chemical Determinants of Brain Penetrance.

Martin G Strebl1,2, Changning Wang1, Frederick A Schroeder1, Michael S Placzek1,3, Hsiao-Ying Wey1, Genevieve C Van de Bittner1, Ramesh Neelamegam1, Jacob M Hooker1.   

Abstract

Despite major efforts, our knowledge about many brain diseases remains remarkably limited. Epigenetic dysregulation has been one of the few leads toward identifying the causes and potential treatments of psychiatric disease over the past decade. A new positron emission tomography radiotracer, [(11)C]Martinostat, has enabled the study of histone deacetylase in living human subjects. A unique property of [(11)C]Martinostat is its profound brain penetrance, a feature that is challenging to engineer intentionally. In order to understand determining factors for the high brain-uptake of Martinostat, a series of compounds was evaluated in rodents and nonhuman primates. The study revealed the major structural contributors to brain uptake, as well as a more clinically relevant fluorinated HDAC radiotracer with comparable behavior to Martinostat, yet longer half-life.

Entities:  

Keywords:  blood-brain barrier; brain penetrance; epigenetics; fluorine; histone deacetylase; positron emission tomography

Mesh:

Substances:

Year:  2015        PMID: 26675505      PMCID: PMC5784429          DOI: 10.1021/acschemneuro.5b00297

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  23 in total

1.  Virtual computational chemistry laboratory--design and description.

Authors:  Igor V Tetko; Johann Gasteiger; Roberto Todeschini; Andrea Mauri; David Livingstone; Peter Ertl; Vladimir A Palyulin; Eugene V Radchenko; Nikolay S Zefirov; Alexander S Makarenko; Vsevolod Yu Tanchuk; Volodymyr V Prokopenko
Journal:  J Comput Aided Mol Des       Date:  2005-06       Impact factor: 3.686

2.  Synthesis and imaging validation of [¹⁸F]MDL100907 enabled by Ni-mediated fluorination.

Authors:  Hong Ren; Hsiao-Ying Wey; Martin Strebl; Ramesh Neelamegam; Tobias Ritter; Jacob M Hooker
Journal:  ACS Chem Neurosci       Date:  2014-06-03       Impact factor: 4.418

Review 3.  New and emerging HDAC inhibitors for cancer treatment.

Authors:  Alison C West; Ricky W Johnstone
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

4.  Template images for nonhuman primate neuroimaging: 1. Baboon.

Authors:  K J Black; A Z Snyder; J M Koller; M H Gado; J S Perlmutter
Journal:  Neuroimage       Date:  2001-09       Impact factor: 6.556

Review 5.  Epigenetics of the depressed brain: role of histone acetylation and methylation.

Authors:  HaoSheng Sun; Pamela J Kennedy; Eric J Nestler
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

6.  Prefrontal cortical dysfunction after overexpression of histone deacetylase 1.

Authors:  Mira Jakovcevski; Rahul Bharadwaj; Juerg Straubhaar; Guangping Gao; David P Gavin; Igor Jakovcevski; Amanda C Mitchell; Schahram Akbarian
Journal:  Biol Psychiatry       Date:  2013-05-07       Impact factor: 13.382

7.  HDAC2 negatively regulates memory formation and synaptic plasticity.

Authors:  Ji-Song Guan; Stephen J Haggarty; Emanuela Giacometti; Jan-Hermen Dannenberg; Nadine Joseph; Jun Gao; Thomas J F Nieland; Ying Zhou; Xinyu Wang; Ralph Mazitschek; James E Bradner; Ronald A DePinho; Rudolf Jaenisch; Li-Huei Tsai
Journal:  Nature       Date:  2009-05-07       Impact factor: 49.962

8.  PET imaging demonstrates histone deacetylase target engagement and clarifies brain penetrance of known and novel small molecule inhibitors in rat.

Authors:  F A Schroeder; C Wang; G C Van de Bittner; R Neelamegam; W R Takakura; A Karunakaran; H Y Wey; S A Reis; J Gale; Y L Zhang; E B Holson; S J Haggarty; J M Hooker
Journal:  ACS Chem Neurosci       Date:  2014-09-19       Impact factor: 4.418

9.  Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylation.

Authors:  Pamela J Kennedy; Jian Feng; A J Robison; Ian Maze; Ana Badimon; Ezekiell Mouzon; Dipesh Chaudhury; Diane M Damez-Werno; Stephen J Haggarty; Ming-Hu Han; Rhonda Bassel-Duby; Eric N Olson; Eric J Nestler
Journal:  Nat Neurosci       Date:  2013-03-10       Impact factor: 24.884

10.  A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests.

Authors:  Frederick A Schroeder; Michael C Lewis; Daniel M Fass; Florence F Wagner; Yan-Ling Zhang; Krista M Hennig; Jennifer Gale; Wen-Ning Zhao; Surya Reis; Douglas D Barker; Erin Berry-Scott; Sung Won Kim; Elizabeth L Clore; Jacob M Hooker; Edward B Holson; Stephen J Haggarty; Tracey L Petryshen
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

View more
  11 in total

1.  Molecular Imaging of Sirtuin1 Expression-Activity in Rat Brain Using Positron-Emission Tomography-Magnetic-Resonance Imaging with [18F]-2-Fluorobenzoylaminohexanoicanilide.

Authors:  Robin Bonomi; Vadim Popov; Maxwell T Laws; David Gelovani; Anjoy Majhi; Aleksandr Shavrin; Xin Lu; Otto Muzik; Nashaat Turkman; Renshyan Liu; Thomas Mangner; Juri G Gelovani
Journal:  J Med Chem       Date:  2018-08-13       Impact factor: 7.446

Review 2.  Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade.

Authors:  George Crișan; Nastasia Sanda Moldovean-Cioroianu; Diana-Gabriela Timaru; Gabriel Andrieș; Călin Căinap; Vasile Chiș
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

Review 3.  Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT.

Authors:  Brian P Rempel; Eric W Price; Christopher P Phenix
Journal:  Mol Imaging       Date:  2017 Jan-Dec       Impact factor: 4.488

Review 4.  Neuroimaging Biomarkers for Alzheimer's Disease.

Authors:  Freddie Márquez; Michael A Yassa
Journal:  Mol Neurodegener       Date:  2019-06-07       Impact factor: 14.195

Review 5.  Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

Authors:  Silvio Aime; Mohammed Al-Qahtani; Martin Behe; Guy Bormans; Giuseppe Carlucci; Jean N DaSilva; Clemens Decristoforo; Adriano Duatti; Philip H Elsinga; Klaus Kopka; Xiang-Guo Li; Zhibo Liu; Robert H Mach; Oskar Middel; Jan Passchier; Marianne Patt; Ivan Penuelas; Ana Rey; Peter J H Scott; Sergio Todde; Jun Toyohara; Danielle Vugts; Zhi Yang
Journal:  EJNMMI Radiopharm Chem       Date:  2021-03-18

Review 6.  HDAC Inhibitors: Innovative Strategies for Their Design and Applications.

Authors:  Mateusz Daśko; Beatriz de Pascual-Teresa; Irene Ortín; Ana Ramos
Journal:  Molecules       Date:  2022-01-21       Impact factor: 4.411

Review 7.  PET Molecular Imaging in Drug Development: The Imaging and Chemistry Perspective.

Authors:  Sridhar Goud Nerella; Priti Singh; Tulja Sanam; Chander Singh Digwal
Journal:  Front Med (Lausanne)       Date:  2022-02-28

8.  Expression of HDAC2 but Not HDAC1 Transcript Is Reduced in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia.

Authors:  Frederick A Schroeder; Tonya M Gilbert; Ningping Feng; Brendan D Taillon; Nora D Volkow; Robert B Innis; Jacob M Hooker; Barbara K Lipska
Journal:  ACS Chem Neurosci       Date:  2016-12-13       Impact factor: 4.418

Review 9.  Advances in the Development of PET Ligands Targeting Histone Deacetylases for the Assessment of Neurodegenerative Diseases.

Authors:  Tetsuro Tago; Jun Toyohara
Journal:  Molecules       Date:  2018-01-31       Impact factor: 4.411

10.  HDAC6 Brain Mapping with [18F]Bavarostat Enabled by a Ru-Mediated Deoxyfluorination.

Authors:  Martin G Strebl; Arthur J Campbell; Wen-Ning Zhao; Frederick A Schroeder; Misha M Riley; Peter S Chindavong; Thomas M Morin; Stephen J Haggarty; Florence F Wagner; Tobias Ritter; Jacob M Hooker
Journal:  ACS Cent Sci       Date:  2017-09-06       Impact factor: 14.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.